computer software program statview for windows version 5.0 (SAS institute)
90
Structured Review
SAS institute
computer software program statview for windows version 5.0
Computer Software Program Statview For Windows Version 5.0, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statview+computer+software+program+version+5%2E0/statview+5+0/pm29970531-70-13-15
Average 90 stars, based on 1 article reviews
Computer Software Program Statview For Windows Version 5.0, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statview+computer+software+program+version+5%2E0/statview+5+0/pm29970531-70-13-15
Average 90 stars, based on 1 article reviews
computer software program statview for windows version 5.0 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: 30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer. Article Snippet: This is the largest institutional series to date to report the safety and efficacy of single-fraction stereotactic body radiation therapy for the treatment of patients with medically inoperable early stage lung cancer.. In comparing outcomes of our 2 single-fraction dose schedules (30 Gy and 34 Gy, respectively), we found that both of the schedules provided equivalent local control and overall survival rates with minimal toxicity.. This study further develops our understanding of the feasibility and appropriateness of lung radiosurgery. Article Title: Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort. Article Snippet: All statistical analyses were carried out using Statview version 5.0 and SAS Article Title: Cardiovascular prognosis in patients with type 2 diabetes: contribution of heart and kidney subclinical damage. Article Snippet: Cardiovascular prognosis in patients with type 2 diabetes: Contribution of heart and kidney subclinical damage Philippe Sosner, MD, Charlotte Hulin-Delmotte, MD, Pierre-Jean Saulnier, MD, PhD, f,g,h Séverin Cabasson, MD, i Elise Gand, MSc, j Florence Torremocha, MD, j Xavier Piguel, MD, j Aurélie Miot, MD, e,j Richard Maréchaud, MD, DanielHerpin,MD,PhD, a,e StéphanieRagot, PharmD,PhD, e,f,g,h andSamyHadjadj,MD,PhD, for theSURDIAGENE Study Group Poitiers, France and Paris, France |